0000950123-20-004802.txt : 20200514
0000950123-20-004802.hdr.sgml : 20200514
20200514095307
ACCESSION NUMBER: 0000950123-20-004802
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20200331
FILED AS OF DATE: 20200514
DATE AS OF CHANGE: 20200514
EFFECTIVENESS DATE: 20200514
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Omega Fund Management, LLC
CENTRAL INDEX KEY: 0001637359
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-16844
FILM NUMBER: 20875668
BUSINESS ADDRESS:
STREET 1: 888 BOYLSTON ST., SUITE 1111
CITY: BOSTON
STATE: MA
ZIP: 02199
BUSINESS PHONE: 617 502 6538
MAIL ADDRESS:
STREET 1: 888 BOYLSTON ST., SUITE 1111
CITY: BOSTON
STATE: MA
ZIP: 02199
FORMER COMPANY:
FORMER CONFORMED NAME: Omega Fund Management (US) Inc.
DATE OF NAME CHANGE: 20150320
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
true
false
0001637359
XXXXXXXX
03-31-2020
03-31-2020
Omega Fund Management, LLC
888 Boylston St., Suite 1111
Boston
MA
02199
13F HOLDINGS REPORT
028-16844
N
Anne-Mari Paster
Chief Financial Officer, Omega Fund Management, LLC
617.502.6538
/s/ Anne-Mari Paster
Boston
MA
05-11-2020
0
16
241630
false
INFORMATION TABLE
2
form13fInfoTable.xml
INFORMATION TABLE FOR FORM 13F
Arcutis Biothereapeutics
Common Stock
03969K108
25171
844680
SH
SOLE
844680
0
0
Beam Therapeutics
Common Stock
07373V105
5451
302821
SH
SOLE
302821
0
0
Cidara Therapeutics
Common Stock
171757107
4980
2008150
SH
SOLE
2008150
0
0
ESSA Pharma
Common Stock
29668H708
6759
1689848
SH
SOLE
1689848
0
0
FibroGen
Common Stock
31572Q808
4540
130646
SH
SOLE
130646
0
0
Gossamer Bio
Common Stock
38341P102
43399
4275726
SH
SOLE
4275726
0
0
Immunic
Common Stock
4525EP101
8298
1371494
SH
SOLE
1371494
0
0
Jounce Therapeutics
Common Stock
481116101
2517
529965
SH
SOLE
529965
0
0
Morphic Holding
Common Stock
61775R105
43593
2969582
SH
SOLE
2969582
0
0
ObsEva
Common Stock
H5861P103
2408
999364
SH
SOLE
999364
0
0
Paratek Pharmaceuticals
Common Stock
699374302
8191
2600410
SH
SOLE
2600410
0
0
Pieris Pharmaceuticals
Common Stock
720795103
1712
750741
SH
SOLE
750741
0
0
Prevail Therapeutics
Common Stock
74140Y101
3326
272807
SH
SOLE
272807
0
0
Replimune Group
Common Stock
76029N106
52825
5323455
SH
SOLE
5323455
0
0
Translate Bio
Common Stock
89374L104
24303
2437603
SH
SOLE
2437603
0
0
Trevi Therapeutics
Common Stock
89532M101
4157
1263408
SH
SOLE
1263408
0
0